| USP订购编号 |
美国药典，USP分析标准品，英文名称，规格 |
CAS编号查询 |
UN编号对照 |
| USP-1374260 |
Magnesium Hydroxide (1 g) |
1309-42-8 |
|
| 2816100000 |
|
|
|
| USP-1374281 |
Magnesium Oxide (500 mg) |
1309-48-4 |
|
| 2519905000 |
|
|
|
| USP-1374292 |
Magnesium Phosphate (2 g) (AS) |
7757-87-1 |
|
| 2835299050 |
|
|
|
| USP-1374306 |
Magnesium Salicylate (200 mg) |
18917-95-8 |
|
| 2918211000 |
|
|
|
| USP-1374361 |
Magnesium Sulfate (1 g) (Magnesium Sulfate (1:1) heptahydrate) |
10034-99-8 |
|
| 2833210000 |
|
|
|
| USP-1374383 |
Powdered Malabar-Nut-Tree, Leaf Extract (1 g) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1374500 |
Maleic Acid (300 mg) |
110-16-7 |
UN3261 |
| USP-1374601 |
Malic Acid (500 mg) |
6915-15-7 |
|
| 2918195000 |
|
|
|
| USP-1374907 |
Maltitol (200 mg) |
585-88-6 |
|
| 2940006000 |
|
|
|
| USP-1375003 |
Maltol (500 mg) |
118-71-8 |
|
| 2932999000 |
|
|
|
| USP-1375025 |
Maltose Monohydrate (500 mg) |
6363-53-7 |
|
| 1702905000 |
|
|
|
| USP-1375047 |
Maltotriose (500 mg) |
1109-28-0 |
|
| 2940006000 |
|
|
|
| USP-1375058 |
Mandelic Acid (500 mg) |
90-64-2 |
|
| 2918191350 |
|
|
|
| USP-1375105 |
Mannitol (1.5 g) |
69-65-8 |
|
| 2905430000 |
|
|
|
| USP-1375156 |
Mangiferin (15 mg) |
4773-96-0 |
|
| 2938900000 |
|
|
|
| USP-1375173 |
Mangifera Indica Bark Dry Extract (500 mg) |
4773-96-0 |
|
| 1302190200 |
|
|
|
| USP-1375182 |
Mannose (500 mg) |
3458-28-4 |
|
| 2940006000 |
|
|
|
| USP-1375207 |
Maprotiline Hydrochloride (200 mg) |
10347-81-6 |
|
| 2921490002 |
|
|
|
| USP-1375241 |
Maprotiline Related Compound D (15 mg) (3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2-en-1-amine, hydrochloride) |
38849-14-8 |
|
| 2921490002 |
|
|
|
| USP-1375295 |
Marmelosin (20 mg) |
482-44-0 |
|
| 2932206000 |
|
|
|
| USP-1375502 |
Mebendazole (200 mg) |
31431-39-7 |
|
| 2933994600 |
|
|
|
| USP-1375524 |
Mebendazole Related Compound D (15 mg) (Methyl 5-benzoyl-1-methylbenzimidazol-2-ylcarbamate) |
132119-11-0 |
|
| 2933998350 |
|
|
|
| USP-1375706 |
Mebrofenin (100 mg) |
78266-06-5 |
|
| 2924296000 |
|
|
|
| USP-1376006 |
Mecamylamine Hydrochloride (200 mg) |
826-39-1 |
UN2811 |
| USP-1376017 |
Mecamylamine Related Compound A (10 mg) (N,1,7,7-Tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride) |
91369-45-8 |
UN2811 |
| USP-1377009 |
Meclizine Hydrochloride (500 mg) |
31884-77-2 |
|
| 2933595960 |
|
|
|
| USP-1377010 |
Meclizine Related Compound A (15 mg) (4-Chlorobenzhydrol) |
119-56-2 |
|
| 2933599550 |
|
|
|
| USP-1377029 |
Meclizine Related Compound B (15 mg) (1-[(4-Chlorophenyl)(phenyl)methyl]-4-(2-methylbenzyl)piperazine dihydrochloride monohydrate) |
N/A |
|
| 2933599550 |
|
|
|
| USP-1377508 |
Meclocycline Sulfosalicylate (300 mg) |
73816-42-9 |
|
| 2941300000 |
|
|
|
| USP-1377803 |
Meclofenamate Sodium (500 mg) |
67254-91-5 |
UN2811 |
| USP-1378001 |
Medroxyprogesterone Acetate (200 mg) |
71-58-9 |
|
| 2937230000 |
|
|
|
| USP-1378012 |
Medroxyprogesterone Acetate Related Compound A (25 mg) (6alpha-Methyl-3,20-dioxopregnan-17-yl acetate) |
N/A |
|
| 2918300000 |
|
|
|
| USP-1378023 |
Medroxyprogesterone Acetate Related Compound B (25 mg) (17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione) |
520-85-4 |
|
| 2937230000 |
|
|
|
| USP-1379059 |
Mefloquine Hydrochloride (100 mg) |
51773-92-3 |
UN3077 |
| USP-1379060 |
Mefloquine Related Compound A (20 mg) (threo-mefloquine) |
N/A |
|
| 2933399095 |
|
|
|
| USP-1379081 |
Calcium D,L-5-Methyltetrahydrofolate (300 mg) |
26560-38-3 |
|
| 2936299055 |
|
|
|
| USP-1379106 |
Megestrol Acetate (250 mg) |
595-33-5 |
|
| 2937230000 |
|
|
|
| USP-1379128 |
Megestrol Acetate Related Compound C (20 mg) (6,17a-beta-Dimethyl-3,17-dioxo-17a-homoandrosta-4,6-diene-17a-alpha-yl acetate) |
74910-22-8 |
|
| 2915399500 |
|
|
|
| USP-1379139 |
Megestrol Acetate Related Compound D (20 mg) (6-Methylene-3,20-dioxopregn-4-en-17-yl acetate) |
32634-95-0 |
|
| 2915399500 |
|
|
|
| USP-1542003 |
Piperazine Phosphate (200 mg) |
14538-56-8 |
|
| 2933599550 |
|
|
|
| USP-1543200 |
Piperine (20 mg) |
94-62-2 |
|
| 2939790000 |
|
|
|
| USP-1544406 |
Piroctone Olamine (200 mg) |
68890-66-4 |
UN3077 |
| USP-1544417 |
Piroctone Related Compound A (15 mg) ((2-[5-methyl-3-(2,4,4-trimethylpentyl)-4,5-dihydroisoxazol-5-yl]acetic acid) 2-aminoethanol salt) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1544508 |
Piroxicam (125 mg) |
36322-90-4 |
UN2811 |
| USP-1544519 |
Piroxicam Related Compound A (50 mg) (Pyridin-2-amine) |
504-29-0 |
UN2671 |
| USP-1544520 |
Piroxicam Related Compound B (50 mg) (4-Hydroxy-N-(pyridin-2-yl)-2H-benzothiazine-3-carboxamide 1,1-dioxide) |
65897-46-3 |
|
| 2934990005 |
|
|
|
| USP-1544541 |
Piroxicam Related Compound D (50 mg) (Methyl 2-[1,1-dioxido-3-oxobenzoisothiazol-2(3H)-yl]acetate) |
6639-62-9 |
|
| 2934990005 |
|
|
|
| USP-1544574 |
Piroxicam Related Compound G (50 mg) (Methyl 4-hydroxy-2H-benzothiazine-3-carboxylate 1,1-dioxide monohydrate) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1544600 |
Piroxicam Related Compound J (50 mg) (Methyl 4-hydroxy-2-methyl-2H-benzothiazine-3-carboxylate 1,1-dioxide) |
35511-15-0 |
|
| 2934990005 |
|
|
|
| USP-1544858 |
Plant Stanol Esters (10 x 100 mg) |
194673-84-2 |
|
| 3824994100 |
|
|
|
| USP-1544927 |
Plastic Additive 1 (100 mg) (Ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl] butanoate]) |
32509-66-3 |
|
| 2918290000 |
|
|
|
| USP-1544938 |
Plastic Additive 2 (200 mg) (pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]) |
6683-19-8 |
|
| 2918290000 |
|
|
|
| USP-1544949 |
Plastic Additive 3 (200 mg) (2,2′,2”,6,6′,6”-hexa-tert-butyl-4,4′,4”-[(2,4,6-trimethyl-1,3,5-benzenetriyl)trismethylene]triphenol) |
1709-70-2 |
|
| 2907299000 |
|
|
|
| USP-1544950 |
Plastic Additive 4 (200 mg) (Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate) |
2082-79-3 |
|
| 2918290000 |
|
|
|
| USP-1544964 |
Plastic Additive 5 (200 mg) (Tris(2,4-di-tert-butylphenyl) phosphite) |
31570-04-4 |
|
| 2920900002 |
|
|
|
| USP-1544971 |
Plastic Additive 6 (200 mg) (1,3,5-Tris(3,5-di-tert-butyl-4-hydroxybenzyl)-s-triazine-2,4,6(1H,3H,5H)-trione) |
27676-62-6 |
|
| 2933690000 |
|
|
|
| USP-1544993 |
Plastic Additive 8 (100 mg) (Dioctadecyl disulfide) |
2500-88-1 |
|
| 2930909265 |
|
|
|
| USP-1545001 |
Plastic Additive 9 (100 mg) (Didodecyl 3,3′-thiodipropionate) |
123-28-4 |
|
| 2930909265 |
|
|
|
| USP-1545012 |
Plastic Additive 10 (100 mg) (dioctadecyl 3,3′-thiodipropionate) |
693-36-7 |
|
| 2930909265 |
|
|
|
| USP-1545023 |
Plastic Additive 11 (100 mg) (Copolymer of Dimethyl Succinate and (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-yl)ethanol)) |
65447-77-0 |
|
| 2930909265 |
|
|
|
| USP-1545034 |
Plastic Additive 12 (100 mg) (Oleamide) |
301-02-0 |
|
| 3404905160 |
|
|
|
| USP-1545045 |
Plastic Additive 13 (100 mg) (Erucamide) |
112-84-5 |
|
| 3404905160 |
|
|
|
| USP-1545090 |
Plastic Additive 18 (5 x 25 mg) |
64685-81-0 |
UN3082 |
| USP-1545409 |
Polacrilex Resin (100 mg) (Methacrylic acid polymer with divinylbenzene) |
NA |
|
| 3914006000 |
|
|
|
| USP-1545500 |
Polacrilin Potassium (200 mg) |
65405-55-2 |
|
| 3914006000 |
|
|
|
| USP-1546106 |
Poloxalene (500 mg) |
9003/11/6 |
|
| 3402491000 |
|
|
|
| USP-1546161 |
Poloxamer Solid (1 g) |
9003/11/6 |
|
| 3402421000 |
|
|
|
| USP-1546194 |
Polydatin (20 mg) (3-Hydroxy-5-[(E)-2-(4-hydroxyphenyl)vinyl]phenyl Beta-D-glucopyranoside) |
27208-80-6 |
|
| 2938900000 |
|
|
|
| USP-1A00510 |
Budesonide Acetaldehyde Acetal (25 mg) (16alpha,17-[(1RS)-ethylidenebis(oxy)]-11beta,21-dihydroxypregna-1,4-diene-3,20-dione) |
1040085-98-0 |
|
| 2932999000 |
|
|
|
| USP-1A00520 |
5-Fluoro Risperidone (25 mg) (3-(2-(4-(5-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one) |
1199589-74-6 |
|
| 2934990005 |
|
|
|
| USP-1A00530 |
N6-(1-Iminoethyl)-D-lysine (10 mg) ((2R)-2-[(2S)-2-Aminobutanamido]butanamide) |
1844123-52-9 |
|
| 2924190002 |
|
|
|
| USP-1A00540 |
Bis((R)-butyramide) (10 mg) ((R)-2-amino-N-((R)-1-amino-1-oxobutan-2-yl)butanamide) |
1867585-44-1 |
|
| 2924190002 |
|
|
|
| USP-1A00550 |
(R)-Clopidogrel Carboxylic Acid (10 mg) ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid) |
324757-50-8 |
|
| 2934990005 |
|
|
|
| USP-1A00560 |
2-Oxo Clopidogrel (Mixture of Diastereomers) (10 mg) (methyl 2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate) |
109904-27-0 |
|
| 2934990005 |
|
|
|
| USP-1A00570 |
2-Oxo R-Clopidogrel (10 mg) (methyl (2R)-2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate) |
1360923-54-1 |
|
| 2934990005 |
|
|
|
| USP-1A00580 |
4-Fluoro Risperidone (需冷链运输) (10 mg) (3-(2-(4-(4-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1A00590 |
7-Fluoro Risperidone (需冷链运输) (10 mg) (3-(2-(4-(7-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1A00600 |
Risperidone Difluoroketone (10 mg) (3-(2-(4-(2,4-difluorobenzoyl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one) |
158697-67-7 |
|
| 2933599550 |
|
|
|
| USP-1A00610 |
Pemetrexed Glutamide Trisodium Salt (25 mg) (((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-4-carboxybutanoyl)-L-glutamic acid, sodium salt) |
1265908-59-5 |
|
| 2933599550 |
|
|
|
| USP-1A00620 |
Pemetrexed Disodium Enantiomer (25 mg) ((2R)-2-[[4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid, sodium salt) |
937370-10-0 |
|
| 2933599550 |
|
|
|
| USP-1A00630 |
Pemetrexed Acid N-Hydroxysuccinimide Ester (25 mg) (2,5-dioxopyrrolidin-1-yl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate) |
204257-65-8 |
|
| 2933599550 |
|
|
|
| USP-1A00640 |
Pemetrexed Dimethyl Ester (25 mg) (dimethyl (4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-L-glutamate) |
155405-81-5 |
|
| 2933599550 |
|
|
|
| USP-1A00650 |
Rivaroxaban Open Ring Methylamine (10 mg) ((S)-4-(4-((2-hydroxy-3-(methylamino)propyl)amino)phenyl)morpholin-3-one) |
2459303-14-9 |
|
| 2934990005 |
|
|
|
| USP-1A00660 |
Rivaroxaban Phthalamide (25 mg) (N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide) |
1365267-36-2 |
|
| 2934990005 |
|
|
|
| USP-1A00670 |
Rivaroxaban Open Ring (10 mg) ((R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide) |
721401-53-2 |
|
| 2934990005 |
|
|
|
| USP-1A00680 |
Budesonide 9(11)-ene (25 mg) ((6aS,8aS,8bS,11aR,12aS,12bS)-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,8,8a,8b,11a,12,12a,12b-decahydro-4H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-4-one) |
313474-58-7 |
|
| 2932999000 |
|
|
|
| USP-1A00690 |
Bromobudesonide (25 mg) ((6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-6b-bromo-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12, 12a,12b-dodecahydro-4H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-4-one) |
313474-59-8 |
|
| 2932999000 |
|
|
|
| USP-1A00700 |
Fluticasone Propionate Acid (25 mg) ((6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15, 16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid) |
65429-42-7 |
|
| 2918992090 |
|
|
|
| USP-1A00720 |
Desiodoamiodarone (25 mg) ((2-butylbenzofuran-3-yl)(4-(2-(diethylamino)ethoxy)phenyl)methanone) |
23551-25-9 |
|
| 2932996560 |
|
|
|
| USP-1A00731 |
Fexofenadine Olefin (25 mg) (2-(4-(4-(4-(diphenylmethylene)piperidin-1-yl)-1-hydroxybutyl)phenyl)-2-methylpropanoic acid) |
1187954-57-9 |
|
| 2933399095 |
|
|
|
| USP-1A00750 |
Tolyloyl Bromopropionamide (25 mg) (3-bromo-N,N-dimethyl-4-oxo-4-(p-tolyl)butanamide) |
836627-56-6 |
|
| 2924296000 |
|
|
|
| USP-1A00760 |
Atorvastatin 3-deoxyhept-2-enoic Acid (25 mg) ((S,E)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxyhept-2-enoic acid) |
1105067-93-3 |
|
| 2933998350 |
|
|
|
| USP-1A00770 |
Diamino Atorvastatin Calcium (25 mg) (Calcium (3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoyl]amino]-3,5-dihydroxyheptanoate) |
1105067-87-5 |
|
| 2933998350 |
|
|
|
| USP-1A00800 |
Atorvastatin Epoxy Tetrahydrofuran Analog (25 mg) (4-(4-Fluorophenyl)-2,4-dihydroxy-2-(1-methylethyl)-N,5-diphenyl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide) |
873950-19-7 |
|
| 2932996560 |
|
|
|
| USP-1A00830 |
Atorvastatin tert-Butyl Ester (25 mg) (tert-butyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate) |
134395-00-9 |
|
| 2933998350 |
|
|
|
| USP-1A00840 |
3′-Demethyl-3′-N-[(4-methylphenyl)sulfonyl]azithromycin (25 mg) |
612069-31-5 |
|
| 2935909550 |
|
|
|
| USP-1A00860 |
Azithromycin C (3”-O-demethylazithromycin) (25 mg) |
620169-47-3 |
|
| 2934990005 |
|
|
|
| USP-1A00880 |
16alpha-Hydroxyprednisolone (25 mg) ((8S,9S,10R,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one) |
13951-70-7 |
|
| 2914409000 |
|
|
|
| USP-1A00890 |
Carvedilol Bisalkylpyrocatechol derivative (25 mg) (3,3′-{2,2′-[1,2-Phenylenebis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol)) |
1346602-98-9 |
|
| 2933998350 |
|
|
|
| USP-1A00910 |
Celecoxib Open Ring (25 mg) (4-((1,1,1-trifluoro-4-hydroxy-4-(p-tolyl)but-3-en-2-ylidene)amino)benzenesulfonamide) |
N/A |
|
| 2935909550 |
|
|
|
| USP-1A00920 |
Desaryl Celecoxib (25 mg) (5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazole) |
948293-46-7 |
|
| 2933194350 |
|
|
|
| USP-1A00930 |
Methyl p-Toluate (25 mg) (Methyl 4-methylbenzoate) |
99-75-2 |
|
| 2916399000 |
|
|
|
| USP-1A00940 |
Duloxetine 4-Naphthyl Isomer Hydrobromide (25 mg) (4-(3-(methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol, hydrobromide) |
949096-01-9 |
|
| 2934990005 |
|
|
|
| USP-1A00950 |
Duloxetine beta-Naphthol-1-yl Isomer (25 mg) (2-(3-(Methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol) |
1033803-59-6 |
|
| 2934990005 |
|
|
|
| USP-1A00960 |
Duloxetine Alcohol (25 mg) ((R)-3-(methylamino)-1-(thiophen-2-yl)propan-1-ol) |
116539-57-2 |
|
| 2934990005 |
|
|
|
| USP-1A00970 |
N-Methyl Duloxetine Oxalate (25 mg) ((S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine, oxalate) |
132335-47-8 |
|
| 2934990005 |
|
|
|
| USP-1A00990 |
Decarboxy Moxifloxacin (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline) (需冷链运输) |
1322062-57-6 |
|
| 2933497050 |
|
|
|
| USP-1A01000 |
Floxacin Amine (25 mg) (7-amino-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) |
172426-88-9 |
|
| 2933497050 |
|
|
|
| USP-1A01010 |
Olanzapine lactam (25 mg) ((Z)-4-(4-methylpiperazin-1-yl)-3-(2-oxopropylidene)-1,3-dihydro-2H-benzo[b][1,4]diazepin-2-one) |
1017241-34-7 |
|
| 2933998350 |
|
|
|
| USP-1A01020 |
Olanzapine thiolactam (25 mg) ((Z)-1-(4-(4-Methylpiperazin-1-yl)-2-thioxo-1,2-dihydro-3H-benzo[b][1,4]diazepin-3-ylidene)propan-2-one) |
1017241-36-9 |
|
| 2933998350 |
|
|
|
| USP-1A01030 |
1,2-Dihydro Fluticasone Propionate (25 mg) |
105613-90-9 |
|
| 2930909265 |
|
|
|
| USP-1A01040 |
11-Ketofluticasone Propionate (25 mg) ((6S,8S,9R,10S,13S,14S,16R,17R)-6,9-Difluoro-17-(((fluoromethyl)thio)carbonyl)-10,13,16-trimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate) |
1219174-94-3 |
|
| 2930909265 |
|
|
|
| USP-1A01050 |
6-Methyl-4-phenylchromanol (25 mg) (6-Methyl-4-phenylchroman-2-ol) |
209747-04-6 |
|
| 2932996560 |
|
|
|
| USP-1A01060 |
6-Methyl-4-phenylchromanone (25 mg) (6-Methyl-4-phenylchroman-2-one) |
40546-94-9 |
|
| 2932206000 |
|
|
|
| USP-1A01070 |
Alpha-Naphthol (Naphthalen-1-ol) (25 mg) |
90-15-3 |
UN2811 |
| USP-1A01080 |
Desethylamiodarone (25 mg) (2-Butyl-3-benzofuranyl-4-[2-(ethylamino)ethoxy]-3,5-diiodophenyl Ketone Hydrochloride) |
96027-74-6 |
|
| 2932996560 |
|
|
|
| USP-1A01090 |
Monoiodoamiodarone (25 mg) ((2-Butylbenzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3-iodophenyl}methanone) |
85642-08-6 |
|
| 2932996560 |
|
|
|
| USP-1A01110 |
Dehydro Desloratadine (25 mg) (8-chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine) |
117811-20-8 |
|
| 2933399095 |
|
|
|
| USP-1A01120 |
Fluticasone sulfenic acid (25 mg) ((6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carbo(thioperoxoic )O-acid) |
948566-12-9 |
|
| 2930909265 |
|
|
|
| USP-1A01130 |
Fluticasone Propionate Trisulfide (25 mg) |
960071-64-1 |
|
| 2930909265 |
|
|
|
| USP-1A01140 |
Pemetrexed Acid (25 mg) (4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid) |
137281-39-1 |
|
| 2933599550 |
|
|
|
| USP-1A01150 |
Pemetrexed Glutamide Sodium (25 mg) ((S)-4-((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-4-carboxybutanamido)-4-carboxybutanoate, sodium salt) |
144051-68-3 (free acid) |
|
| 2933599550 |
|
|
|
| USP-1A01160 |
Rivaroxaban Amine (25 mg) ((S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, hydrochloride) |
898543-06-1 |
|
| 2934990005 |
|
|
|
| USP-1A01170 |
Rivaroxaban Glycolic Acid Analog (25 mg) ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid) |
931204-39-6 |
|
| 2934990005 |
|
|
|
| USP-1A01180 |
Chlorothiophene carboxylic acid (25 mg) (5-chlorothiophene-2-carboxylic acid) |
24065-33-6 |
|
| 2934990005 |
|
|
|
| USP-1A01190 |
Rivaroxaban N-acyl glycolic acid (25 mg) ((S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid) |
1151893-81-0 |
|
| 2934990005 |
|
|
|
| USP-1A01200 |
Rosuvastatin Lactone (25 mg) (N-[4-(4-Fluorophenyl)-5-{(E)-2-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]vinyl}-6-isopropylpyrimidin-2-yl]-N-methylmethanesulfonamide) |
503610-43-3 |
|
| 2935909550 |
|
|
|
| USP-1A01210 |
Deoxyprednisolone-16-ene Acetate (25 mg) (2-((8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate) |
3044-42-6 |
|
| 2918992090 |
|
|
|
| USP-1A01220 |
16Alpha-Hydroxy Prednisolone-14-ene Acetate (25 mg) (2-Oxo-2-((8R,9S,10R,11S,13S,16R,17S)-11,16,17-trihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)ethyl acetate) |
131918-72-4 |
|
| 2918992090 |
|
|
|
| USP-1A01230 |
16Alpha-Hydroxy Prednisolone-14-ene (25 mg) ((8R,9S,10R,11S,13S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one) |
=”131918-73-5 |
|
| 2914409000 |
|
|
|
| USP-1A01240 |
16Alpha-Hydroxy-11-keto Prednisolone Acetate (25 mg) (2-((8S,9S,10R,13S,14S,16R,17S)-16,17-dihydroxy-10,13-dimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate) |
3949-79-9 |
|
| 2918992090 |
|
|
|
| USP-1A01250 |
16Alpha-Hydroxy-11-keto Prednisolone (25 mg) (8S,9S,10R,13S,14S,16R,17S)-16,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthrene-3,11(6H)-dione) |
3754-05-0 |
|
| 2914409000 |
|
|
|
| USP-1A01260 |
16Alpha-Hydroxy Prednisolone-9(11)-ene (25 mg) ((8S,10S,13S,14S,16R,17S)-16,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,10,12,13,14,15,16,17-decahydro-3Hcyclopenta[a]phenanthren-3-one) |
39672-76-9 |
|
| 2914409000 |
|
|
|
| USP-1A01270 |
16Alpha-Hydroxy Prednisolone-9(11)-ene Acetate (25 mg) (2-((8S,10S,13S,14S,16R,17S)-16,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate) |
77017-20-0 |
|
| 2918992090 |
|
|
|
| USP-1A01280 |
16Alpha-Hydroxy Prednisolone-9(11)-ene Diacetate (25 mg) (2-((8S,10S,13S,14S,16R,17S)-16-acetoxy-17-hydroxy-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate) |
95943-95-6 |
|
| 2918992090 |
|
|
|
| USP-1A01290 |
TEMED Dihydrochloride (25 mg) (N1,N1,N2,N2-tetramethylethane-1,2-diamine, hydrochloride) |
7677-21-6 |
|
| 2921290055 |
|
|
|
| USP-1A01300 |
Bis(dimethylaminoethyl) Ether Dihydrochloride (25 mg) (2,2′-oxybis(N,N-dimethylethan-1-amine), hydrochloride) |
103526-47-2 |
|
| 2922199695 |
|
|
|
| USP-1A01320 |
Dimethylethylamine Hydrochloride (25 mg) (N,N-dimethylethanamine, hydrochloride) |
58114-25-3 |
|
| 2921196190 |
|
|
|
| USP-1A01330 |
Bis(2-methylaminoethyl) Ether Hydrochloride (25 mg) (2,2′-oxybis(N-methylethan-1-amine), hydrochloride) |
295796-12-2 |
|
| 2922199695 |
|
|
|
| USP-1A01340 |
2,3-Dimethyl-2,3-butanediamine Dihydrochloride (25 mg) (2,3-dimethylbutane-2,3-diamine, hydrochloride) |
75804-28-3 |
|
| 2921290055 |
|
|
|
| USP-1A01360 |
Clopidogrel-Beta-D-glucuronide (10 mg) ((2S,3S,4S,5R,6S)-6-((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid) |
1314116-53-4 |
|
| 2934990005 |
|
|
|
| USP-1A01370 |
Budesonide 21-butyrate (25 mg) (2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-10-propyl-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl butyrate) |
2408495-96-3 |
|
| 2932999000 |
|
|
|
| USP-1A01380 |
Clopidogrel Quaternary Salt (25 mg) (5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-6,7-dihydrothieno[3,2-c]pyridin-5-ium, bromide) |
2418591-12-3 |
|
| 2934990005 |
|
|
|
| USP-1A01390 |
6alpha-Hydroxybudesonide (25 mg) ((2S,6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-2,7-Dihydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-4-one) |
577777-51-6 |
|
| 2932999000 |
|
|
|
| USP-1A01400 |
6Beta-Hydroxybudesonide (25 mg) ((2R,6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-2,7-dihydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-4-one) |
88411-77-2 |
|
| 2932999000 |
|
|
|
| USP-1A01420 |
Desonide 21-Acetate (2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-Hydroxy-6a,8a,10,10-tetramethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl acetate) |
25092-25-5 |
|
| 2932999000 |
|
|
|
| USP-1A01430 |
Clopidogrel Piperidinylidene Analog (25 mg) ((E)-2-(1-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4-((2-(3-methoxyphenyl)-2-oxoethyl)thio)piperidin-3-ylidene)acetic acid) |
N/A |
|
| 2933399095 |
|
|
|
| USP-1A01450 |
Chloro N-methylthiophene Carboxamide (25 mg) (5-chloro-N-methylthiophene-2-carboxamide) |
97799-98-9 |
|
| 2934990005 |
|
|
|
| USP-1A01460 |
Rivaroxaban Open Chain Dithiophene Analog (10 mg) ((S)-5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-(methylamino)-2-oxoethoxy)ethyl)thiophene-2-carboxamide) |
1807455-76-0 |
|
| 2934990005 |
|
|
|
| USP-1A01470 |
Rivaroxaban Desmorpholinone Analog (25 mg) ((S)-5-chloro-N-((3-(4-((2-hydroxyethyl)amino)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide) |
936232-22-3 |
|
| 2934990005 |
|
|
|
| USP-1A01480 |
Desthiophenerivaroxaban Methylcarbamate Analog (25 mg) (methyl ((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)carbamate) |
1838139-08-4 |
|
| 2934990005 |
|
|
|
| USP-1A01490 |
Methylisoindolinedione (25 mg) (2-methylisoindoline-1,3-dione) |
550-44-7 |
|
| 2925190100 |
|
|
|
| USP-1A01500 |
Desthiophenerivaroxaban Phthalimodo Analog (25 mg) ((R)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione) |
1424944-35-3 |
|
| 2934990005 |
|
|
|
| USP-1A01510 |
Rivaroxaban Desthiophene Analog (25 mg) ((R)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one) |
1411775-06-8 |
|
| 2934990005 |
|
|
|
| USP-1A01520 |
Rivaroxaban N-methylphthalamido Analog (25 mg) ((S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide) |
2206360-74-7 |
|
| 2934990005 |
|
|
|
| USP-1A01530 |
Aminophenylmorpholinone (25 mg) (4-(4-aminophenyl)morpholin-3-one) |
438056-69-0 |
|
| 2934990005 |
|
|
|
| USP-1A01540 |
(S)-Glycidyl Phthalimide (25 mg) ((S)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione) |
161596-47-0 |
|
| 2925190100 |
|
|
|
| USP-1A01570 |
Rivaroxaban Phthalimido Analog (25 mg) ((R)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione) |
446292-07-5 |
|
| 2934990005 |
|
|
|
| USP-1A01580 |
Dichlorothiophene Carboxylic Acid (25 mg) (3,5-dichlorothiophene-2-carboxylic acid) |
89166-94-9 |
|
| 2934990005 |
|
|
|
| USP-1A01590 |
Nitrophenylchlorothiophene Carboxylate (25 mg) (4-nitrophenyl 5-chlorothiophene-2-carboxylate) |
1450877-56-1 |
|
| 2934990005 |
|
|
|
| USP-1A01600 |
Diphthalimido Morpholinone Analog (25 mg) (2,2′-((2R,2’R)-((4-(3-oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione)) |
1643354-27-1 |
|
| 2934990005 |
|
|
|
| USP-1A01610 |
Aminophenylmorpholin-2-one (25 mg) (4-(4-aminophenyl)morpholin-2-one) |
1456733-00-8 |
|
| 2934990005 |
|
|
|
| USP-1A01620 |
Tolterodine Dimer (25 mg) (2,2′-((isopropylazanediyl)bis(1-phenylpropane-3,1-diyl))bis(4-methylphenol)) |
854306-72-2 |
|
| 2922299000 |
|
|
|
| USP-1A01630 |
Tolyloyl Propionamide (25 mg) (N,N-Dimethyl-4-oxo-4-(p-tolyl)butanamide) |
402470-91-1 |
|
| 2924296000 |
|
|
|
| USP-1A01640 |
Tolyloyl Propionic Acid (25 mg) (4-Oxo-4-(p-tolyl)butanoic Acid) |
4619-20-9 |
|
| 2918300000 |
|
|
|
| USP-1A01650 |
3-Hydroxy Desloratadine (25 mg) (8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-3-ol) |
119410-08-1 |
|
| 2933399095 |
|
|
|
| USP-1A01660 |
N-Hydroxy Desloratadine (25 mg) (4-(8-Chloro-5,6-dihydro-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-piperidin-1-ol) |
1193725-73-3 |
|
| 2933399095 |
|
|
|
| USP-1A01670 |
N-Acetyl Desloratadine (25 mg) (1-[4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl]ethanone) |
117796-52-8 |
|
| 2933399095 |
|
|
|
| USP-1A01690 |
Ticlopidine Pyridinium Bromide Analog (25 mg) (5-(2-chlorobenzyl)-6,7-dihydrothieno[3,2-c]pyridin-5-ium, bromide) |
801319-16-4 (free base) |
|
| 2934990005 |
|
|
|
| USP-1A01700 |
Clopidogrel Open Ring Hydrochloride (25 mg) (methyl (S)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride) |
141109-19-5 |
|
| 2934990005 |
|
|
|
| USP-1A01710 |
Methyl 2-chloro-Beta-D-phenylalanine (25 mg) (methyl (R)-2-amino-2-(2-chlorophenyl)acetate, hydrochloride) |
212838-70-5 |
|
| 2922493800 |
|
|
|
| USP-1A01720 |
Open Ring N-Methyl Clopidogrel Hydrochloride (25 mg) (methyl (S)-2-(2-chlorophenyl)-2-(methyl(2-(thiophen-2-yl)ethyl)amino)acetate, hydrochloride) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1A01730 |
Clopidogrel Ethyl Ester Sulfate (25 mg) (ethyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate) |
1332612-57-3 |
|
| 2934990005 |
|
|
|
| USP-1A01740 |
Desfluorociprofloxacin Hydrochloride (25 mg) (1-cyclopropyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid, hydrochloride) |
2727369-47-1 |
|
| 2933599550 |
|
|
|
| USP-1A01750 |
Desfluorocitalopram Oxalate (25 mg) (1-(3-(dimethylamino)propyl)-1-phenyl-1,3-dihydroisobenzofuran-5-carbonitrile, oxalate) |
1093072-86-6 |
|
| 2932996560 |
|
|
|
| USP-1A01760 |
Escitalopram Open Ring (25 mg) (4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile) |
103146-25-4 |
UN3077 |
| USP-1A01770 |
5-Dimethylaminobutyryl Citalopram Oxalate (25 mg) (4-(dimethylamino)-1-(1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-yl)butan-1-one, oxalate) |
N/A |
|
| 2932996560 |
|
|
|
| USP-1A01780 |
Escitalopram Acid Analog (25 mg) (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxylic acid) |
440121-09-5 |
|
| 2932996560 |
|
|
|
| USP-1A01790 |
N-Methyl Lacosamide (25 mg) ((R)-2-(N-methylacetamido)-N-benzyl-3-methoxypropanamide) |
N/A |
|
| 2924296000 |
|
|
|
| USP-1A01800 |
Lacosamide Acrylamide Analog (25 mg) (2-Acetamido-N-benzylacrylamide) |
86921-49-5 |
|
| 2924296000 |
|
|
|
| USP-1A01810 |
N-Benzylacetamide (N-Acetylbenzylamine) (25 mg) |
588-46-5 |
|
| 2924296000 |
|
|
|
| USP-1A01820 |
Ureidolacosamide (25 mg) ((R)-N-Benzyl-2-(3-benzylureido)-3-methoxypropanamide) |
2295925-90-3 |
|
| 2924296000 |
|
|
|
| USP-1A01830 |
Isobutylglutarmonoamide (R-isomer) (25 mg) ((R)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid) |
181289-33-8 |
|
| 2924190002 |
|
|
|
| USP-1A01840 |
Isobutylglutarmonoamide (25 mg) (3-(2-Amino-2-oxoethyl)-5-methylhexanoic Acid) |
181289-15-6 |
|
| 2924190002 |
|
|
|
| USP-1A01850 |
Tetrahydrothienopyridine Hydrochloride (25 mg) (4,5,6,7-Tetrahydrothieno[3,2-c]pyridine, hydrochloride) |
28783-41-7 |
|
| 2934990005 |
|
|
|
| USP-1A01860 |
Clopidogrel Amide (25 mg) ((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide) |
444728-13-6 |
|
| 2934990005 |
|
|
|
| USP-1A01870 |
Clopidogrel R-Enantiomer (25 mg) ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide) |
444728-15-8 |
|
| 2934990005 |
|
|
|
| USP-1A01890 |
Clopidogrel N-Oxide (25 mg) (5-((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide) |
1319197-71-1 |
|
| 2934990005 |
|
|
|
| USP-1A01900 |
Clopidogrel Open Ring R-enantiomer (25 mg) (methyl (R)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride) |
1258938-54-3 |
|
| 2934990005 |
|
|
|
| USP-1A01910 |
Iodofluticasone Propionate (25 mg) |
80474-67-5 |
|
| 2930902000 |
|
|
|
| USP-1A01920 |
Fexofenadine N-oxide (25 mg) (1-(4-(4-(2-carboxypropan-2-yl)phenyl)-4-hydroxybutyl)-4-(hydroxydiphenylmethyl)piperidine 1-oxide) |
1422515-52-3 |
|
| 2933399095 |
|
|
|
| USP-1A01930 |
Tacrolimus 5E-ene (25 mg) |
104987-16-8 |
|
| 2934990005 |
|
|
|
| USP-1A01940 |
Methoxycyclohexanol methacrylic aldehyde (25 mg) ((E)-3-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-2-methylacrylaldehyde) |
109466-74-2 |
|
| 2912499500 |
|
|
|
| USP-1A01960 |
Levamlodipine (25 mg) (3-ethyl 5-methyl (S)-2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate) |
103129-82-4 |
|
| 2933399095 |
|
|
|
| USP-1A02000 |
Budesonide Pyruvic Acid (25 mg) (2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-10-propyl-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoacetic acid) |
N/A |
|
| 2932999000 |
|
|
|
| USP-1A02010 |
17alpha-Hydroxy13(17)a-homoprednisolone (25 mg) ((2R,3R,4aS,4bS,10aR,10bS,11S,12aS)-2,3,11-trihydroxy-2-(hydroxymethyl)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydrochrysene-1,8(2H,4bH)-dione) |
N/A |
|
| 2937290000 |
|
|
|
| USP-1A02030 |
4′-Hydroxycelecoxib (25 mg) (4-(5-(4-(hydroxymethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide) |
170571-00-3 |
|
| 2935909550 |
|
|
|
| USP-1A02110 |
rac-Clopidogrel Acid N-Oxide (25 mg) (5-(carboxy(2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1A02120 |
Clopidogrel Diester Enantiomer Sulfate (25 mg) ((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl (R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1A02160 |
4-Hydroxy Duloxetine Acetate (25 mg) ((S)-4-(3-(methylamino)-1-(thiophen-2-yl)propoxy)naphthalen-1-ol, acetate) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1A02170 |
Duloxetine Phenylcarbamate (50 mg) (phenyl (S)-methyl(3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)carbamate) |
947686-09-1 |
|
| 2934990005 |
|
|
|
| USP-1A02180 |
rac-Duloxetine-d7 Maleate (25 mg) (N-methyl-3-((naphthalen-1-yl-d7)oxy)-3-(thiophen-2-yl)propan-1-amine, maleate) |
N/A |
|
| 2845900100 |
|
|
|
